Abstract
Early recognition of anthracycline-induced cardiomyopathy may reduce morbidity and mortality in children, but risk stratification tools are lacking. This study evaluates whether electrocardiogram (ECG) changes precede echocardiographic abnormalities in children with anthracycline-induced cardiomyopathy. We performed a retrospective analysis of 589 pediatric cancer patients who received anthracyclines at a tertiary referral center. ECG endpoints were sum of absolute QRS amplitudes in the 6 limb leads (ΣQRS(6 L)) and corrected QT interval (QTc). Cardiomyopathy was defined by echocardiogram as ejection fraction < 50%, shortening fraction < 26%, or left ventricular end-diastolic diameter z-score > 2.5. Median age at start of therapy was 7.8 years (IQR 3.7-13.6); median follow-up time was 3.6 years (IQR 1.1-5.8). 19.5% of patients met criteria for cardiomyopathy. Male sex, race, older age at first dose, and larger body surface area were associated with development of cardiomyopathy. A 0.6 mV decrease in ΣQRS(6 L) and 10 ms increase in QTc were associated with an increased risk of developing cardiomyopathy with hazard ratios of 1.174 (95% CI = 1.057-1.304, p = 0.003) and 1.098 (95%CI = 1.027-1.173, p = 0.006) respectively. Kaplan-Mei...Continue Reading
References
Jul 1, 1992·The American Journal of Cardiology·R L LarsenG Barber
Mar 21, 1991·The New England Journal of Medicine·S E LipshultzS P Sanders
Jun 29, 1995·The New England Journal of Medicine·S E LipshultzS D Colan
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C L SchwartzE B Clark
Jun 1, 1996·Journal of Chemotherapy·S FerrariG Bacci
Oct 12, 2001·Clinical Cardiology·D IarussiA Iacono
Apr 4, 2003·Cancer·Keld SorensenIan D Sullivan
May 27, 2003·Cancer·Sandra M SwainMichael S Ewer
Jun 28, 2005·Paediatric Drugs·Valeriano C SimbreSteven E Lipshultz
Oct 3, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elvira C van DalenLeontien C M Kremer
Jan 12, 2008·Pediatrics·Sadhna M ShankarUNKNOWN Cardiovascular Disease Task Force of the Children's Oncology Group
Jul 5, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Pieter G PostemaArthur A M Wilde
Aug 19, 2011·Pediatric Blood & Cancer·Dursun AlehanMünevver Büyükpamukçu
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CuriglianoUNKNOWN ESMO Guidelines Working Group
Oct 2, 2013·Circulation·Steven E LipshultzUNKNOWN American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council
Jun 21, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Saro H ArmenianSmita Bhatia
May 8, 2015·Circulation·Daniela CardinaleCarlo M Cipolla
Aug 28, 2016·European Heart Journal·Jose Luis ZamoranoUNKNOWN ESC Scientific Document Group
Apr 30, 2017·Pediatric Blood & Cancer·Timothy M MarkmanSaman Nazarian
Nov 18, 2017·Journal of the American College of Cardiology·Hui-Ming ChangEdward T H Yeh
Jul 1, 2015·European Cardiology·Susan E Piper, Theresa A McDonagh